Lifetime high calcium intake increases osteoporotic fracture risk in old age

被引:11
作者
Klompmaker, TR [1 ]
机构
[1] Groove Union Coop UA, NL-1051 BP Amsterdam, Netherlands
关键词
D O I
10.1016/j.mehy.2005.04.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Caloric restriction prolongs life span. Calcium restriction may preserve bone health. In osteoporosis, bone mineral density (BMD) has significantly decreased, due to a tack of osteoblast bone formation. Traditional osteoporosis prevention is aimed at maximizing BMD, but the lifetime effects of continuously maintaining a high BMD on eventual bone health in old age, have not been studied. Strikingly, in countries with a high mean BMD, fracture rates in the elderly are significantly higher than in countries with a Low mean BMD. Studies show that this is not based on genetic differences. Also, in primary hyperparathyroidism, on the brink of osteoporosis, BMD levels may be significantly higher than normal. Maybe, BMD does not represent long term bone health, but merely momentary bone strength. And maybe, maintaining a high BMD might actually wear out bone health. Since osteoporosis particularly occurs in the elderly, and because in osteoporotic bone less osteoblasts are available, the underlying process may have to do with ageing of osteoblastic cells. In healthy subjects, osteoblastic bone cells respond to the influx of calcium by composing a matrix upon which calcium precipitates. In the process of creating this matrix, 50-70% of the involved osteoblasts die. The greater the influx of calcium, the greater osteoblast activity, and the greater osteoblast apoptosis rate. An increased osteoblast apoptosis rate leads to a decrease in the age-related osteoblast replicative capacity (ARORC). In comparison to healthy bone, in osteoporotic bone the decrease in the replicative capacity of osteoblastic cells is greater. Due to the eventual resulting lack of osteoblast activity, micro-fractures cannot be repaired. Continuously maintaining a high BMD comes with continuously high bone remodeling rates, which regionally exhaust the ARORC, eventually leading to irreparable microfractures. Regarding long time influences on bone health, adequate estrogen levels are known to be protective against osteoporosis. This is generally attributed to its inhibiting influence on osteoclast activity. Instead, its net effects on osteoblast metabolism may be the key to osteoporosis prevention. Adequate estrogen levels inhibit osteoblast activity, calcium apposition and osteoblast apoptosis rate, preserving the ARORC. Conclusion: Regarding osteoporosis prevention, ARORC better than BMD represents bone health. Regarding ARORC, adequate estrogen levels are protective, opposing the similar effects of hyperparathyroidism and a high calcium diet. Tests need to be performed in mice to assess the lifetime effects of a high versus a low calcium diet, on eventual bone fracture toughness. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 104 条
[1]   Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice [J].
Alexander, JM ;
Bab, I ;
Fish, S ;
Müller, R ;
Uchiyama, T ;
Gronowicz, G ;
Nahounou, M ;
Zhao, Q ;
White, DW ;
Chorev, M ;
Gazit, D ;
Rosenblatt, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (09) :1665-1673
[2]   IMPAIRED OSTEOBLAST FUNCTION IN OSTEOPOROSIS - COMPARISON BETWEEN CALCIUM BALANCE AND DYNAMIC HISTOMORPHOMETRY [J].
ARLOT, M ;
EDOUARD, C ;
MEUNIER, PJ ;
NEER, RM ;
REEVE, J .
BRITISH MEDICAL JOURNAL, 1984, 289 (6444) :517-520
[3]  
Aspray TJ, 1996, J BONE MINER RES, V11, P1019
[4]  
Bonewald L. F., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P101
[5]   Differential patterns of osteoblast dysfunction in trabecular bone in patients with established osteoporosis [J].
Byers, RJ ;
Denton, J ;
Hoyland, JA ;
Freemont, AJ .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (09) :760-764
[6]   Mechanisms of glucocorticoid action in bone [J].
Canalis, E ;
Delany, AM .
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 :73-81
[7]   Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects [J].
Chen, QX ;
Kaji, H ;
Iu, MF ;
Nomura, R ;
Sowa, H ;
Yamauchi, M ;
Tsukamoto, T ;
Sugimoto, T ;
Chihara, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4655-4658
[8]   BONE MASS AND EXERCISE [J].
CHESNUT, CH .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 :S34-S36
[9]  
Christiansen P, 2001, APMIS, V109, P5
[10]   Long-term effects of parathyroid hormone, 1,25-dihydroxyvitamin D3, and dexamethasone on the cell growth and functional activity of human osteogenic alveolar bone cell cultures [J].
Costa, MA ;
Fernandes, MH .
PHARMACOLOGICAL RESEARCH, 2000, 42 (04) :345-353